Clinical trial
To Compare the Efficacy and Safety of TW vs Valsartan in the MN
NCT00518219 is registered in ClinicalTrials.gov with Nanjing University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Compare the Efficacy and Safety of TW vs Valsartan in the MN
- Lead sponsor
- Nanjing University School of Medicine
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2007
- Completion date
- September 30, 2009
- Enrollment
- 68 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
membranous nephropathy